Utility of genetics for risk stratification in pediatric hypertrophic cardiomyopathy.

Abstract excerpt

Children with hypertrophic cardiomyopathy (HCM) experience sudden cardiac death (SCD) and other life-threatening events. We assessed if affected gene and variant burden predict outcomes. Patients <18 years old with primary HCM with a pathogenic variant or variant of uncertain significance in cardiomyopathy genes were included. Association of gene and variant number and type with freedom from major adverse cardiac...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Pediatrics
• Share to Cardiac Myosins
• Share to Cardiomyopathy, Hypertrophic